Clinical Trial: A Study on the Efficacy and Safety of Sonrotoclax Combined with the DCEG Regimen in Patients with TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of Sonrotoclax Combined with the DCEG Regimen in Patients with TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133541

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Huadong Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339158

Published by HT Digital Content Services with permission from Health Daily Digest....